Saved Results

No results saved yet.

Enter a patient name and hit Save on a result.

Clinical calculator summary

CHIPS (Childhood Hodgkin Score)

The Childhood Hodgkin International Prognostic Score (CHIPS) is used to risk-stratify pediatric patients.

Evidence-based context for fast calculator use

Purpose:
CHIPS score stratifies pediatric Hodgkin Lymphoma risk to guide treatment intensification or de-escalation based on stage, bulk, and B-symptoms.
Population:
patients with the specific hematologic diagnosis and disease phase described by the model
Factors:
Stage IV Disease?, Large Mediastinal Bulk?, B-Symptoms?, Albumin < 3.5 g/dL?
Reference:
Landman-Parker J, et al. J Clin Oncol. 2024 update; COG AHOD0031/AHOD1331.
HomeCHIPS (Childhood Hodgkin Score)
Pin your most used calculators here by clicking the star in the dropdown.

CHIPS (Childhood Hodgkin Score)

Clinical Context & Background

The Childhood Hodgkin International Prognostic Score (CHIPS) is used to risk-stratify pediatric patients. A higher score helps identify candidates for treatment intensification, while a score of 0 suggests potential for treatment de-escalation to minimize long-term toxicity.
Primary Source EvidenceLandman-Parker J, et al. J Clin Oncol. 2024 update; COG AHOD0031/AHOD1331.
Formula Logic
Sum of 4 factors: Stage IV, Mediastinal Bulk, B-Symptoms, and Albumin < 3.5 g/dL

Reference Data

CHIPS ScoreRisk GroupEstimated 4-Year EFS
0Low Risk93-95%
1Intermediate Risk88-91%
2-4High Risk75-83%

Clinical Workflow

Use, Interpret, And Continue The Patient Pathway

Expand for workflow guidance, limitations, examples, and related next steps.

When To Use

  • Use CHIPS (Childhood Hodgkin Score) when cHIPS score stratifies pediatric Hodgkin Lymphoma risk to guide treatment intensification or de-escalation based on stage, bulk, and B-symptoms.
  • Confirm that the patient, diagnosis, disease phase, and available inputs match the cited model before calculation.

How To Interpret

  • Interpret the displayed result using the calculator-specific formula and reference table, spanning 0 through 2-4.
  • A boundary result should prompt input verification and clinical review rather than false precision.

What To Do Next

  • Confirm morphology, molecular/cytogenetic data, treatment timing, laboratory units, and the current disease-specific guideline before acting.
  • Document the inputs, result, timing, and clinical context so the assessment can be reproduced.

Limitations

  • Hematology scores are diagnosis-, phase-, and treatment-specific and should not be transferred between diseases.
  • The result supports clinician judgment and does not independently determine treatment.

Validated Population

patients with the specific hematologic diagnosis and disease phase described by the model

How to apply this result

For a representative case, verify Stage IV Disease?, Large Mediastinal Bulk?, B-Symptoms?, calculate the result, and confirm that its classification matches the highlighted reference band before continuing the disease-specific pathway.

Hematology hubContinue to related calculators and clinical workflow resources.

Share This Calculator

Share:

Related Tools

NCCN-IPI (Lymphoma)CLL-IPIMIPI (Mantle Cell Lymphoma)

Frequently Asked Questions

When should CHIPS (Childhood Hodgkin Score) be used?

Use it for patients with the specific hematologic diagnosis and disease phase described by the model when all required inputs and the intended clinical setting are confirmed.

Can CHIPS (Childhood Hodgkin Score) determine treatment by itself?

No. Interpret the result with the cited evidence, complete clinical assessment, current guidelines, and patient-specific goals.

Evidence-based oncology decision support. Verify with clinical guidelines.